Cancer Clinical Trials in New York, New York
29 studies are recruiting for cancer in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Desi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- NYU Langone Medical Center, New York, New York
- Locations
- 16 in total
- Run by
- A2 Biotherapeutics Inc.
-
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
- Locations
- 3 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medications. The main questions the researchers are trying to answer are: * Does the tailored intervention increase adherence? * Does the tailore…
- Stage
- Not phased
- Ages
- 15 to 24
- Site
- Columbia University Irving Medical Center, New York, New York
- Locations
- 4 in total
- Run by
- Children's Hospital Medical Center, Cincinnati
-
A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare
The purpose of this study is to find out whether the Making Cents of Medical Costs (MCMC) program is acceptable, appropriate, accessible, and practical (feasible) for young adult cancer survivors.
- Stage
- Not phased
- Ages
- 18 to 39
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Run by
- Memorial Sloan Kettering Cancer Center
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis
The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurren…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Columbia University Irving Medical Center, New York, New York
- Locations
- 31 in total
- Run by
- Massachusetts General Hospital
-
FOG-001 in Locally Advanced or Metastatic Solid Tumors
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Locations
- 33 in total
- Run by
- Parabilis Medicines, Inc.
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researchers will also study …
- Stage
- Phase 2
- Ages
- 15 to 40
- Site
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact pa…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Pan Tumor Rollover Study
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Local Institution, New York, New York
- Locations
- 399 in total
- Run by
- Bristol-Myers Squibb
-
Evaluation of Grief Therapy Approaches for Bereaved Parents
The purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Supportive Counseling, a…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Locations
- 5 in total
- Run by
- University of Miami
-
Childhood Cancer Survivor Study
The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximate…
- Stage
- Not phased
- Ages
- Any age
- Site
- Memorial-Sloan Kettering Cancer Center, New York, New York
- Locations
- 31 in total
- Run by
- St. Jude Children's Research Hospital
-
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell products in subjects with solid tumors including colorectal cancer (CRC), pancreatic cancer (PANC), non-small cell lung cancer (NSCLC), ovarian cancer (OVCA), mesothelioma (MESO), and other solid tumors that express mesotheli…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- NYU Langone Medical Center, New York, New York
- Locations
- 12 in total
- Run by
- A2 Biotherapeutics Inc.
-
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Research Site, New York, New York
- Locations
- 12 in total
- Run by
- Alterome Therapeutics, Inc.
-
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral temozolomide for the treatment of your newly diagnosed glioblastoma multiforme (GBM). Capecitabine is an oral chemotherap…
- Stage
- Phase 1
- Ages
- 18 to 74
- Site
- Lenox Hill Brain Tumor Center, New York, New York
- Run by
- Northwell Health
-
A Study of Herbal Supplements in Cancer Survivors With Constipation
The purpose of this study is to find out whether MZRW is an effective treatment for constipation in cancer survivors. The researchers will compare MZRW with placebo, a pill that looks like MZRW and is given in the same way, but contains no medication. The researchers will also study the effect MZRW…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Locations
- 21 in total
- Run by
- Immatics US, Inc.
-
A New Psychotherapy Intervention for Older Cancer Patients
This study is being done to see if a new psychotherapy intervention called Cancer and Aging: Reflections for Elders (CARE) can effectively treat depression and distress in older cancer patients. CARE is a 5-session intervention that takes place over the phone. This study will compare CARE with the …
- Stage
- Not phased
- Ages
- 70 and older
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Run by
- Memorial Sloan Kettering Cancer Center
-
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with immunotherapy that blocks the activity of proteins called programed death-1(PD-1) or programmed death ligand-1 (PD-L1). Immuno…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
-
Prospective Study to Assess a Diagnostic Aid for Cancer
The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.
- Stage
- Not phased
- Ages
- 45 and older
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Locations
- 39 in total
- Run by
- Harbinger Health
-
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Columbia University Irving Medical Center, New York, New York
- Locations
- 17 in total
- Run by
- MBrace Therapeutics
-
Food and Microbiome Longitudinal Investigation (FAMiLI)
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
- Stage
- Not phased
- Ages
- 40 and older
- Site
- New York University School of Medicine, New York, New York
- Run by
- NYU Langone Health
-
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
This is a study in patients with newly diagnosed cancer to prospectively evaluate the feasibility of integration of a visual communication tool for patients/caregivers/providers by determining whether such a tool can increase overall satisfaction with the patient experience.
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- NYU Langone Health, New York, New York
- Run by
- NYU Langone Health
-
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions
This is a randomized control trial of patients with suspected malignant pleural effusions to compare whether patients who have a thoracentesis or pleuroscopy (pleural biopsy) obtain an adequate biopsy, achieve a diagnosis, and begin cancer-directed therapy faster.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mount Sinai West, New York, New York
- Locations
- 2 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
This study is being done to attempt to identify genetic mutations or other gene-based variations in adults and children who have cancer, or are likely to develop an inherited form of cancer, and potentially reduce their risk for cancer or treat the cancer earlier.
- Stage
- Not phased
- Ages
- Any age
- Site
- Memorial Sloan Kettering Cancer Center, New York, New York
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Cryopreservation of Ovarian Tissue
The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.
- Stage
- Not phased
- Ages
- Up to 45
- Site
- Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, New York
- Run by
- Weill Medical College of Cornell University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.